ClinicalTrials.Veeva

Menu

Effect of Artronat on the Quality of Life of Patient With Osteoarthritis

L

Lescuyer Laboratory

Status

Completed

Conditions

Osteoarthritis

Treatments

Dietary Supplement: PLACEBO
Dietary Supplement: ARTRONAT

Study type

Interventional

Funder types

Industry
Other

Identifiers

NCT01356199
2011-A00319-32

Details and patient eligibility

About

The purpose of this study is to determine whether the nutritional supplement ARTRONAT improves the quality of life of patients with osteoarthritis.

Full description

Osteoarthritis is a degenerative disease that greatly impairs the quality of life of patients. A nutritional supplement may help, in association with the normal treatment of osteoarthritis, improving the quality of life of such patients, in reducing pain and/or improving join flexibility.

Enrollment

7 patients

Sex

All

Ages

40 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age 40-75 years
  • BMI 18.5-30
  • osteoarthritis type II or III

Exclusion criteria

  • osteoarthritis type I or IV
  • allergy to one of the component of the supplement
  • blood pressure > 14/8
  • history of knee surgery

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

7 participants in 2 patient groups, including a placebo group

ARTRONAT
Experimental group
Treatment:
Dietary Supplement: ARTRONAT
PLACEBO
Placebo Comparator group
Treatment:
Dietary Supplement: PLACEBO

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems